Free Trial
→ Banks aren’t ready for this altcoin—are you? (From Crypto 101 Media) (Ad) Buy AKTX Stock  Free AKTX Stock Alerts

Akari Therapeutics (AKTX) SEC Filings & 10K Form

Akari Therapeutics logo
$1.19 +0.02 (+1.64%)
Closing price 06/13/2025 03:48 PM Eastern
Extended Trading
$1.19 0.00 (0.00%)
As of 09:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Akari Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
06/12/2025
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:00 PM		Akari Therapeutics (Filer)
Form PRE 14A
05/15/2025
7:58 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
05/06/2025
4:23 PM		Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/29/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
3:33 PM		Akari Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
7:50 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:10 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4/A
01/13/2025
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:05 AM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:05 AM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
4:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:30 PM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Billionaires are piling into this gold investment (Ad)

Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scrambling to buy gold coins and bars. But some savvy investors have used a different way to profit from gold bull runs — a special investment with a long history of making 13 times … 21 times … 157 times … even a surprising 1,000 times more than physical gold.

Click here to see how to make the most out of this historic gold bull market.
12/06/2024
3:00 PM		Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
Form SC 13D/A
12/03/2024
4:48 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:50 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2024
3:48 PM		Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/18/2024
7:02 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:27 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
5:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:51 AM		Akari Therapeutics (Subject)
Form 425
10/14/2024
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
10/11/2024
3:52 PM		Akari Therapeutics (Filer)
Form 424B3
10/09/2024
3:27 PM		Akari Therapeutics (Filer)
Form S-4/A
10/04/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
5:34 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:43 AM		Akari Therapeutics (Filer)
Form S-4/A
09/18/2024
3:34 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:36 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
3:40 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2024
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
09/13/2024
4:30 PM		Akari Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
09/06/2024
4:23 PM		Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/06/2024
4:07 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K/A
08/19/2024
3:30 PM		Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:15 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:15 PM		Akari Therapeutics (Filer)
Form NT 10-Q
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
WILLIAMS DONALD A (Reporting)
WILLIAMS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Hashad Mohamed Wa'el Ahmed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Grissinger Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
6:30 AM		Akari Therapeutics (Subject)
RPC Pharma Ltd (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AKTX) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Billionaires are piling into this gold investment
Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...
Weiss Ratings | Sponsored
[First Look] Get in before potential 10X AI announcements
Go for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...
Masters in Trading | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
The one deadline Elon can't afford to miss...
For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...
Brownstone Research | Sponsored
Get in stocks now - and get out on this date
Good News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...
Chaikin Analytics | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored